Driving Rx Adherence In Value-Based Insurance Design Needs More Than Lower Copays – Harvard Researcher
Executive Summary
Value-based insurance design offers the promise of offering better quality care and helping to reduce costs, but getting there will require more than trying to influence behavior by reducing copayments, Harvard’s Choudhry said in a recent webinar.
You may also be interested in...
Improved Drug Adherence Tied To Five Value-Based Insurance Design Features In Study
Researchers found better adherence associated with reduced copays, targeting high-risk patients, wellness programs, mail order incentives and the lack of a concurrent disease management program.
PCORI In Brief: New Board Member, Funding Opportunities
The Patient-Centered Outcomes Research Institute welcomes UCSF professor Alicia Fernandez to the board, announces pragmatic trials funding opportunity; Senate bids farewell to PCORI champion Max Baucus.
Merck-Backed Medication Adherence Plan Says Reducing Copays Is Part Of The Solution
National Council on Patient Information and Education releases a series of recommendations aimed at improving medication adherence in a campaign supported by Merck.